Skip to main content
OpenTrials
Completed

NCT Number: NCT01990131

Computerized Anxiety Treatment for Suicide

The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal ideation, and substance use disorders.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anxiety Anxiety Disorders Behavior Behavioral Symptoms Mental Disorders Self-Injurious Behavior Suicide

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Anxiety and Behavioral Health Clinic

Tallahassee, Florida, 32304, United States

About this study

CATS is a newly developed computerized treatment targeting specific risk factors associated with anxiety symptoms and suicidal thoughts. Individuals will be asked to complete four appointments, where they will complete various self-report questionnaires as well as a newly developed computerized treatment targeting risk factors associated with anxiety.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meet diagnostic criteria for a primary Axis 1 anxiety disorder or meet diagnostic criteria for a unipolar mood disorder along with an Axis 1 anxiety disorder.
  • Show evidence of current suicidal ideation (BSS above 6.
  • Show elevated AS indicated by scoring at or above the community sample mean on the ASI-Cog (above 9.

Exclusion criteria

  • No significant medical illness (e.g. sig cardiovascular disease, epilepsy, stroke).
  • Current or past psychotic-spectrum disorders or uncontrolled bipolar disorder
  • No current substance dependence
  • Must be an English speaker.
  • Must be 18 years or older.
  • Must have normal or corrected vision
  • Cannot begin treatment/therapy within 1 month of baseline.
  • Cannot begin a new medication within 3 months of baseline.

Treatment and study plan

Cognitive Anxiety Sensitivity Treatment

Other

Other names: Computerized Anxiety Treatment for Suicide (CATS)

Physical Health Education Training

Other

Primary outcomes

  1. Anxiety Sensitivity Index-3 (ASI-3)

    Time frame: Month 4 follow-up

    The ASI-3 is an 18-item self-report measure of anxiety sensitivity (AS). This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the original ASI provides. Each subfactor is represented by six items. The measure has shown good psychometric properties.

Secondary outcomes

  1. Beck Suicide Scale (BSS)

    Time frame: Month 4 follow-up

    The BSS is a 21-item widely used self-report measure assessing a broad spectrum of behaviors and attitudes related to suicide risk, including suicidal ideation and past suicide attempts. It has demonstrated strong reliability and validity.

Sponsors and collaborators

Lead sponsor

Florida State University

Other

Registry information

Official study title

Suicide Risk Prevention Among Patients With Anxiety Psychopathology

Acronym: CATS

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Nov 21, 2013
Registry last updated
Aug 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.